A total of 912 Private Equity/Venture Financing deals (pending and completed) were announced in the Pharmaceuticals of the North America region, in the last twelve months resulting in a total deal value of over $44,544.9 million. In the LTM period, July 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $11,468.3 million, resulting in an average deal value of $155.0 million during that month. On the other hand, the month of June 2021 was the most prolific in terms of deal volume, recording a total of 91 deals, resulting in an average deal value of $38.2 million during that month.
Of the 912 deals, the deal secured between EQT AB; EQT Partners AB; Goldman Sachs Asset Management LP and Parexel International Corp, was the largest Private Equity/Venture Financing deal in the North America Pharmaceuticals sector, which was valued at $8,500.0 million and was completed on July 2, 2021. The second-largest deal was between Patient Square Capital LP and Summit Behavioral Healthcare LLC, while the third-largest deal was between Andreessen Horowitz LLC; Avidity Partners LLC; Bain Capital Life Sciences; Boxer Capital LLC; BVF Partners LP; Fidelity Management & Research Company; Franklin Templeton Investments Corp; Invus LP; Mubadala Capital; Mubadala Investment Co; Rock Springs Capital Management LP; SB Northstar LP; Verily Life Sciences and EQRx Inc. The Patient Square Capital LP-Summit Behavioral Healthcare LLC deal and the Andreessen Horowitz LLC; Avidity Partners LLC; Bain Capital Life Sciences; Boxer Capital LLC; BVF Partners LP; Fidelity Management & Research Company; Franklin Templeton Investments Corp; Invus LP; Mubadala Capital; Mubadala Investment Co; Rock Springs Capital Management LP; SB Northstar LP; Verily Life Sciences-EQRx Inc deal were valued at $1,300.0 million and $1,200.0 million, respectively. The fourth-largest deal was between Gurnet Point Capital Ltd; Patient Square Capital LP-Radius Health Inc valued at $890.0 million, whereas the deal between aMoon Partners; Andreessen Horowitz LLC; D1 Capital Partners; Founders Fund; General Atlantic LLC; Khosla Ventures LLC; Lightspeed Management Company, L.L.C; Marius Nacht; Playground Global LLC-Ultima Genomics Inc valued at $600.0 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $12,490.0 million and accounted for nearly 28.04% of the total deals (by value) announced during the last twelve months. The North America region accounted for 55.40% of the total Private Equity/Venture Financing deals done globally, and accounted for 7.69% of the total deal size on a global scale.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward